Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy
1Cancer Research UK, Molecular and Cellular Pharmacology Group, School of Biological Sciences, University of Manchester, Manchester, UK M13 9PT.
Abstract:
Major advances have been made in our understanding of the regulation of the molecular machinery of apoptosis in vitro. Molecules linking proliferation and apoptosis in healthy cells are being identified and here apoptotic cell death provides the 'fail-safe' mechanism to counteract excess proliferation. More recently, pioneering work on the regulation of apoptosis, in animal models of tumour development, has shown that suppression of apoptosis in the presence of a proliferative stimulus is sufficient for tumour development. Progress has also been made towards clarifying the contribution of drug-induced apoptosis to tumour response. With increasing evidence that failure to engage apoptosis after drug treatment contributes to drug resistance in vivo comes renewed confidence that new therapeutic approaches based on drug targets in apoptotic pathways will improve the treatment of cancer patients. As ever, tumour specificity is the major issue to be resolved.
Insights
Apoptosis, or programmed cell death, is crucial for preventing cancer by counteracting cell proliferation. Suppressing apoptosis can lead to tumor development, highlighting its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Death Research
Background:
- Apoptosis regulation is key to understanding healthy cell function and disease.
- Molecules linking cell proliferation and apoptosis are being identified.
- Dysregulation of apoptosis contributes to tumor development and drug resistance.
Purpose of the Study:
- To review advances in understanding apoptosis regulation.
- To explore the role of apoptosis in tumor development and response to therapy.
- To discuss the potential of targeting apoptosis for cancer treatment.
Main Methods:
- In vitro studies of apoptosis molecular machinery.
- In vivo studies using animal models of tumor development.
- Analysis of drug-induced apoptosis and its contribution to tumor response.
Main Results:
- Apoptosis acts as a fail-safe mechanism against excess proliferation in healthy cells.
- Suppression of apoptosis, with a proliferative stimulus, is sufficient for tumor development.
- Failure to induce apoptosis after drug treatment contributes to drug resistance.
Conclusions:
- Targeting apoptotic pathways offers promising therapeutic strategies for cancer.
- Tumor specificity remains a critical challenge for apoptosis-based therapies.
- Further research is needed to translate these findings into effective clinical treatments.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:31The Intrinsic Apoptotic Pathway